18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Clinical trial NCT06503146 · RECRUITING

Trial details

NCT number: NCT06503146
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sarcoma Small Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC)Mesothelioma Pheochromocytoma/Paraganglioma (PPGL)Pancreatic Ductal Adenocarcinoma Ovarian Cancer Hepatocellular Carcinoma Gastric Cancer Cholangiocarcinoma Bladder Cancer

Start date: 2025-09-09
Primary completion: 2028-06-01
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.